drugset
drugset / Trial / NCT00505583

Study Evaluating Oral MOA-728 in Subjects on Methadone Therapy

NCT00505583 ↗

Phase 1 Withdrawn Bausch Health Americas, Inc.
RandomizedCrossoverDouble-blindTreatment

Summary

To evaluate the effects of single oral doses of MOA-728 compared to a positive control in subjects on methadone therapy.

Timeline

Start
2007-07
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylnaltrexone Other / unclassified — —

Indications

No indication recorded.